Medtronic gets approval for platelet assay:
This article was originally published in Clinica
Executive Summary
Medtronic has received US FDA marketing clearance for its HemoStatus platelet function test. The assay will be marketed worldwide as a family of disposable, six-channel cartridges for the company's Hepcon haemostasis management system. The initial marketing target will be cardiopulmonary bypass, but Medtronic's blood management unit hopes to expand applications to include other cardiac settings and clinical laboratories.
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.